Nature News: NgAgo gene-editing controversy escalates in peer-reviewed papers# Biology - 生物学
n*p
1 楼
http://www.nature.com/news/ngago-gene-editing-controversy-escalates-in-peer-reviewed-papers-1.21023
摘录：
- Wensheng Wei, a molecular biologist at Peking University has already made
his mind up about NgAgo. “It simply doesn't work, period,” he says.
- Han told Nature he has discovered a problem that would not have been
obvious to others and that could explain why others are having difficulty
replicating his results. He says that he is currently running confirmatory
experiments so that he can publish data and a protocol that satisfies his
critics. “I cannot say right now because the media in China jumps on
everything I say,” he told Nature. “I need a little bit of time.”
- One of the few scientists who previously told Nature he had corroborated
Han’s findings – but has not published these results – now says that he
is using NgAgo for experiments related to his research, and that he hopes to
publish soon. But another who previously noted positive initial results
with NgAgo says now that the “data are confusing” and “we cannot make a
conclusion”. Neither wanted to be named for fear of being dragged into the
controversy.
摘录：
- Wensheng Wei, a molecular biologist at Peking University has already made
his mind up about NgAgo. “It simply doesn't work, period,” he says.
- Han told Nature he has discovered a problem that would not have been
obvious to others and that could explain why others are having difficulty
replicating his results. He says that he is currently running confirmatory
experiments so that he can publish data and a protocol that satisfies his
critics. “I cannot say right now because the media in China jumps on
everything I say,” he told Nature. “I need a little bit of time.”
- One of the few scientists who previously told Nature he had corroborated
Han’s findings – but has not published these results – now says that he
is using NgAgo for experiments related to his research, and that he hopes to
publish soon. But another who previously noted positive initial results
with NgAgo says now that the “data are confusing” and “we cannot make a
conclusion”. Neither wanted to be named for fear of being dragged into the
controversy.